«1 Â.Ñ. Ïèêàëþê, Å.Þ. Áåññàëîâà, Â.Â. Òêà÷ (ìë.), Ì.À. Êðèâåíöîâ, Â.Â. Êèñåëåâ, Ë.Ð. Øàéìàðäàíîâà Êàôåäðà ËÈÊÂÎÐ íîðìàëüíîé ÊÀÊ ...»
247. Õà÷àòðÿí Â.À. Êîìïëåêñíîå ëå÷åíèå ïðîãðåäèåíòíûõ ôîðì ýïèëåïñèè: àâòîðåô. äèñ. íà ñîèñêàíèå ó÷. ñòåïåíè êàíä.
ìåä. íàóê: / Â.À. Õà÷àòðÿí. –Ë., 1986.
248. Õëóíîâñêèé À.Í. Êîíöåïöèÿ áîëåçíè ïîâðåæäåííîãî ìîçãà / À. Í. Õëóíîâñêèé, À. À. Ñòàð÷åíêî. –ÑÏá: Ëàíü, 1999.
249. Õîäîðîâñüêèé Ã.². Ìåõàí³çìè íåðâîâî¿ ³ ãîðìîíàëüíî¿ âçàºìî䳿 / Ã.². Õîäîðîâñüêèé // Áóêîâèíñüêèé ìåäè÷íèé â³ñíèê. – 2004. – Ò. 8, ¹ 1. – Ñ. 7–14.
Êàôåäðà 250. Öâåòàíîâà Å.Ì. Ëèêâîðîëîãèÿ: Ïåð. ñ áîëã./ Å.Ì. Öâåòàíîâà. – Ê.: Çäîðîâ’ÿ, 1986. – 372 ñ.
251. Öåéòëèí Ñ.Ì., Á.À. Âîñêîáîéíèêîâà Áèîëîãè÷åñêàÿ àêòèâíîñòü ñïèííîìîçãîâîé æèäêîñòè è êðîâè ïðè òàê íàçûâàåìîì íîðìàëüíîé ýìîöèîíàëüíîì âîçáóæäåíèè öåíòðàëüíîé íåðâíîé ñèñòåìû / Ñ.Ì. Öåéòëèí // Áþëëåòåíü ýêñïåðèìåíòàëüíîé áèîëîãèè è ìåäèöèíû. – 1937. –Ò.4, ¹ 1. – Ñ. 75–78.
252. Öåéòëèí Ñ.Ì. Áèîëîãè÷åñêàÿ àêòèâíîñòü ñïèííîìîçãîâîé àíàòîìèè æèäêîñòè è êðîâè ïðè ýêñïåðèìåíòàëüíîé ýïèëåïñèè / Ñ.Ì. Öåéòëèí, Â.Ä. Ðîêèòÿíñêèé // Áþëëåòåíü ýêñïåðèìåíòàëüíîé áèîëîãèè è ìåäèöèíû. – 1937. – Ò.4, ¹ 1. – Ñ. 79–82.
253. Öåðåáðîñïèíàëüíàÿ æèäêîñòü /Å.Ï. Þðèùåâ, Ã.Ô. Äîáðîâîëüñêèé, Â.Ô. Èìùåíåöêàÿ, Å.ß. Ùåðáàêîâà // ÁÌÝ. – ÊÃÌÓ 3–å èçä. – Ì.: ÑÝ, 1988. – Ò. 27. – Ñ. 177.
254. Öûìáàëþê Â.È. Íåéðîãåííûå ñòâîëîâûå êëåòêè/ Â.È. Öûìáàëþê, Â.Â. Ìåäâåäåâ. –Ê., 2005. –596 ñ.
255. ×àçîâ Å.È. Õèìè÷åñêàÿ àñèììåòðèÿ ìîçãà / Å. È. ×àçîâ, Í.Ï. Áåõòåðåâà, Ã. ß. Áàêàëêèí è äð. // Íàóêà â ÑÑÑÐ. – 1987. – ¹1.
– Ñ. 21-30.
256. ×åðâÿê Ï.². Ìåäè÷íà åíöèêëîïåä³ÿ / Ï.². ×åðâÿê.– Ê.: Âèä.
öåíòð ïðîñâ³òà, 2001. – 1024 ñ.
257. ×åøêî Ë.À. Ðóññêèé ÿçûê: Ó÷åáíîå ïîñîáèå äëÿ ïîäãîòîâèòåëüíûõ îòäåëåíèé íåãóìàíèòàðíûõ ôàêóëüòåòîâ âóçîâ / Ë.À. ×åøêî. – Ì.: Âûñøàÿ øêîëà, 1961. – 261 ñ.
258. Øàìáóðîâ Ä.À. Ñïèííîìîçãîâàÿ æèäêîñòü/ Ä.À. Øàìáóðîâ. – Ì.: Ìåäãèç, 1954. – 280 ñ.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 259. Øåíäåðîâà Ð.È. Ñîñòîÿíèå ìåñòíîãî èììóíèòåòà ó áîëüíûõ ñ âîñïàëèòåëüíûìè çàáîëåâàíèÿìè ïîçâîíî÷íèêà / Ð.È. Øåíäåðîâà, Â.Â. Îëåéíèê, Î.À. ßêóíîâà // Ïðîáëåìû òóáåðêóëåçà. – 2001. – ¹ 5. – Ñ. 22–24.
260. Øïðàõ Â.Â. Ëèêâîðîñîðáöèÿ â êîìïëåêñíîé òåðàïèè òÿæåëûõ ôîðì ïåðâè÷íûõ ãíîéíûõ ìåíèíãèòîâ / Â.Â. Øïðàõ, Ñ.Ì. Ãîðáà÷åâà, Â.È. Ãîðáà÷åâ //Íåâðîëîãè÷åñêèé æóðíàë. –1997.
–¹3. –Ñ. 17-19.
261. Øòåðí Ë.Ñ. Íåïîñðåäñòâåííàÿ ïèòàòåëüíàÿ ñðåäà îðãàíîâ è òêàíåé. Ôèçèîëîãè÷åñêèå ìåõàíèçìû, îïðåäåëÿþùèå åå ñîñòàâ è Êàôåäðà ñâîéñòâà / Ë.Ñ. Øòåðí. – Ì.: Èçä–âî ÀÍ ÑÑÑÐ, 1960. – 551 ñ.
262. Øòåðí Ë.Ñ. Ïðîáëåìû ãèñòîãåìàòè÷åñêèõ áàðüåðîâ/ Ë.Ñ. Øòåðí. – Ì.: Íàóêà, 1965. – 331 ñ.
263. Øóëåâ Þ.À. Ïðèìåíåíèå ëèêâîðîñîðáöèè â íîðìàëüíîé íåéðîðåàíèìàòîëîãèè / Þ.À. Øóëåâ, Â.Í. Áèêìóëëèí, À.À. Ñòàð÷åíêî //VI Âñåðîññèéñêèé ñúåçä àíåñòåçèîëîãîâ è ðåàíèìàòîëîãîâ. –Ì, 1998. –Ñ.263.
264. Øóëüãèí Ã.Ò. Âëèÿíèå êñåíîãåííîé ñïèííîìîçãîâîé àíàòîìèè æèäêîñòè íà òå÷åíèå âîññòàíîâèòåëüíîãî ïåðèîäà ïîñëå îñòðîé êðîâîïîòåðè: àâòîðåô. äèñ. êàíä. ìåä. íàóê: 14.00.16/ Ã.Ò. Øóëüãèí.
– Ñèìôåðîïîëü, 1981. – 131 ñ.
265. Ùåïèòêèí È.À. Ôàêòîð íåêðîçà îïóõîëè êàê ïîëèïåïòèäíûé ôàêòîð ðîñòà / È.À. Ùåïèòêèí // Óñïåõè ÊÃÌÓ ñîâðåìåííîé áèîëîãèè. – 1993. – Ò. 113, ¹ 5. – Ñ. 617–625.
266. Ýéíøòåéí Ý. Áåëêè ìîçãà è ñïèííîìîçãîâîé æèäêîñòè â íîðìå è ïàòîëîãèè: Ïåð. ñ àíãë. / Ý. Ýéíøòåéí. – Ì.: Ìèð, 1988.
– 280 ñ.
267. Ýêñïåðèìåíòàëüíîå òåñòèðîâàíèå «äèñôóêöèíîâ», èçâëå÷åííûõ ïðè ëèêâîðîñîðáöèè ó áîëüíûõ ñ ãåðîèíîâîé íàðêîìàíèåé / Í.À. Àðñåíèåâ, Þ.Í. Áåëüñêèõ, Â.Ã. Øàëÿïèíà è ñîàâò. // Ýôôåðåíòíàÿ òåðàïèÿ. – 2000. – Ò.3. – Ñ.20-24.
268. Þðåíêîâà Ñ.Ï. Ê âîïðîñó îá èçáèðàòåëüíîñòè èñïîëüçóåìûõ ñîðáåíòîâ ïðè ýêñòðàêîðïîðàëüíîé î÷èñòêå ëèêâîðà ó íåéðîõèðóðãè÷åñêèõ áîëüíûõ / Ñ.Ï. Þðåíêîâà, Ò.Â. Õàðèòîíîâà // III ñúåçä íåéðîõèðóðãîâ Ðîññèè. –ÑÏá, 2002. – Ñ. 451-452.
269. Aberrated levels of cerebrospinal fluid chemokines in 164 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ Guillain–Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy / R. Press, M. Pashenkov, J.–P. Jin, H. Link // Journal of Clinical Immunology. – 2003. – Vol. 23, ¹ 4. – Ð. 259–267.
270. Abraham A.D. 3H–testosterone distribution and binding in rat thymus cells in vivo / A.D. Abraham, G. Bug // Mol Cell Biochem. – 1976. – Vol. 13. – P. 157–63.
271. Adguhr E. Ube rein zentrales Sinnesorgan bei den vertebraten / E.Adguhr // Z. Anat. Entwgesch. – 1922. – Vol. 66. – P. 223–360.
272. Adinolfi A. Alfa–fetoprotein during development and in desease / À. Adinolfi, Ì. Adinolfi, M.H.Lessof // J. Med. Genet. – 1975.
Êàôåäðà – Vol.12. – P. 138.
273. Akefeldt A. Cerebrospinal fluid neuropeptide Y in Prader– Willi syndrome / À. Akefeldt, R. Ekman, J.Mansson // Developmental Medicine & Child Neurology. – 2001. – Vol. 43, ¹ 4. – Ð. 286–287.
íîðìàëüíîé 274. Alpha–melanocyte–stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease / L. Rainero, J.A. Kaye, C. May et al. // Arch. neurol. – 1988. – Vol. 45, ¹ 11. – P. 1224–1227.
àíàòîìèè 275. Analysis of tryptophan and tyrosine in cerebrospinal fluid by capillary electrophoresis and ''ball lens'' UV–pulsed laser–induced fluorescence detection / C. Bayle, N. Siri, V. Poinsot et al. // Journal of Chromatography A. – 2003. – Vol. 1013, ¹ 1–2. – Ð. 123–130.
276. Angelow S. Functional characterisation of the active ascorbic ÊÃÌÓ acid transport into cerebrospinal fluid using primary cultured choroid plexus cells / S. Angelow, Ì. Haselbach, Í.- J.Galla // Brain Research.
– 2003. – Vol. 988, ¹ 1–2. – Ð. 105–113.
277. Armstrong C. S. Uptake of circulating insulin–like growth factor–I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF–II mRNA content in diabetic rat brain / Ñ. S.
Armstrong, L. Wuarin, D.N. Ishii // J. Neurosci. Res. – 2000. – Vol. 59, ¹ 5. – P. 649–660.
278. Arrenbrecht S. Specific binding of growth hormone to thymocyies / S. Arrenbrecht // Nature. – 1974. – Vol. 252. – P. 255–257.
279. Assies J. Protein hormones in the cerebrospinal fluid:
Evidence for retrograde transport from the pituitary to the brain in man / Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ J.Assies, À. Schellekens, J.L. Touber // Clin. Endocr. – 1978. – Vol. 8, ¹ 2. – P. 487–491.
280. Baehr C. Choroid plexus epithelial monolayers – a cell culture model from porcine brain / C. Baehr, V. Reichel, G. Fricker // Cerebrospinal Fluid Research. – 2006. – Vol. 3, ¹13. – P. 1–14.
281. Banks W.A. Selective, physiological transport of insulin across the blood–brain barrier: novel demonstration by species–specic radioimmunoassays / W.A. Banks, J.B. Jaspan, A.J. Kastin // Peptides. – 1997. – Vol. 18, ¹8. – P. 1257–1262.
282. Becher Burchard. Brain–immune connection: Immuno– Êàôåäðà regulatory properties of CNS–resident cells / Becher Burchard, Prat Alexandre, Ð. Antel Jack // Glia. – 2000. – Vol. 29, ¹ 4. – P. 293–304.
283. Bechter K. Cerebrospinal fluid filtration as experimental treatment in a case of Borna disease vims-encephalitis-related íîðìàëüíîé schizophrenia. 4th Symposium on the neurovirology and neuroimmunology of shizophrenia and bipolar disorder 5–7 november Bethesda. – Maryland, 1998. –Ð.123.
284. Berciano J. Cerebrospinal fluid filtration for treating Guillain àíàòîìèè Barre syndrome is there any pathological background / Berciano J. // Anaesthesia. –2000. –Vol. 55, ¹ 4. –Ð. 408.
285. Bleier R. The relations of ependima to neurons and capillaries in the hypothalamus: a Golgi–cox study / R. Bleier // J. Comp. Neurol. – 1971. – Vol. 142, ¹ 4. – P. 439–463.
ÊÃÌÓ 286. Blood–brain barrier transport of cationised immunoglobulin G:
enchanced delivery compared to native protein / Triguero D., Buciac J.B., Yang J., Pardridge W.M. // Proc. Nat. Acad. Sci. USA – 1989. – Vol. 86, ¹ 12. – P. 4761–4765.
287. Blood–brain, blood–cerebrospinal fluid and cerebrospinal fluid–brain barriers in a marsupial (macropus eugenii) during development / K. M. Dziegielewska, L. A. Hinds, K. Mollgard et al. // Journal of Physiology. – 1988. – Vol. 403. – P.367–388.
288. Bouchaud C. Serotoninergic innervations of ependimal cells in the rat subcomissural organ. A fluorescence electron microscopic and radioautographic study / Ñ. Bouchaud, Ì. Arfuison // Biol. Cell. – 1977.
– Vol. 30, ¹ 1. – P. 61–64.
166 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 289. Bradbury M.W.B. Transport of iron in the blood–brain– cerebrospinal fluid system / M.W.B. Bradbury // Journal of Neurochemistry. – 1997. – Vol. 69. – P. 443–454.
290. Brain–derived neurotrophic factor in cerebrospinal fluid of patients with chronic daily headache: relationship with nerve growth factor and glutamate levels / P. Sarchielli, A. Alberti, B. Gallai et al. // The Journal of Headache and Pain. – 2002. – Vol. 3. – Ð. 129–135.
291. Bulat M. Biochemical communication of the brain and cerebrospinal fluid / Ì. Bulat // Periodicum Biologorum. – 1980. – Vol.82. – P. 251– Êàôåäðà 292. Cake M.H., Litwack G. The glucocorticoid receptors / Ì.Í.
Cake, Litwack G. // Biochemical Actions of Hormones. – 1975. – Vol 3.
– Ð. 90.
293. Caulaert van C. Sur la presence de l’hormone íîðìàëüíîé prehypophysaire excite–secretrice de la thyroide dans le sang et le liquid cephalorachidien et sur la repartition dans ces milieux / Ñ. Caulaert van, Ì. Aron, Stahl J. // Comp. Rend. Soc. Biol. – 1931. – Vol. 106. – P.
607–609.
àíàòîìèè 294. Cerebrospinal fluid “pheresis” in Guillain-Barre syndrome / Wollinsky K.H., Hulser P.J., Westarp M.E. et al. //Med Hypoth. –1992.
–Vol. 38. –Ð. 155-165.
295. Cerebrospinal fluid adrenomedullin levels in patients with pre–eclampsia / O. Celik, S. Hascalik, M. Yurekli, Y. Turkoz // Acta ÊÃÌÓ Obstetricia Et Gynecologica Scandinavica. – 2003. – Vol. 82, ¹ 6. – Ð.
578–579.
296. Cerebrospinal uid affects phenotype and functions of myeloid dendritic cells / M. Pashenkov, M. Soderstrom, Y.–M. Huang et al. // Clin Exp Immunol. – 2002. – Vol. 128. – P. 379–387.
297. Cerebrospinal fluid and plasma concentrations of POMC–related peptides in multiple sclerosis / L. Pinessi, I. Rainero, Ò. de Gennaro et al. // Ann N Y Acad Sci. – 1992. – Vol. 650, ¹ 7. –P. 351–354.
298. Cerebrospinal fluid and plasma concentrations of SRIH, beta– endorphin, CRH, NPY and GHRH in obese and normal weight subjects / A. Brunani, C. Invitti, A. Dubini et al. // J. Obes. Relat. Metab. Disord. – 1995. – Vol. 19, ¹ 1. – P. 17–21.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 299. Cerebrospinal fluid and plasma leptin measurements:
covariability with dopamine and cortisol in fasting humans / M.M.
Hagan, P.J. Havel, R.J. Seeley et al. // J. Clin. Endocrinol. Metab. – 1999. – Vol. 84, ¹ 10. – P. 3579–3585.
300. Cerebrospinal fluid and serum protein levels of tumor necrosis factor–alpha (TNF–), interleukin–6 (IL–6) and soluble interleukin– receptor (sIL–6R gp80) in multiply sclerosis patient / S.A. Vladic, G.
Horvat, S. Vukadin et al. // Cytokine. – 2002. – Vol. 20, ¹ 2. – Ð. 86–89.
301. Cerebrospinal fluid concentrations of corticotropin–releasing hormone, vasopressin, and somatostatin in depressed patients and Êàôåäðà healthy controls: response to amitriptyline treatment / I. Heuser, G.
Bissette, M. Dettling et al. // Depress Anxiety. – 1998. – Vol. 8, ¹ 2. – P. 71–79.
302. Cerebrospinal fluid concentrations of somatostatin and íîðìàëüíîé biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions / J.D. Coplan, R.C. Trost, M.J. Owens et al. // Arch. Gen. Psychiatry. – 1998. – Vol. 55, ¹ 5. – P. 473–477.
303. Cerebrospinal fluid cytokines in AIDS dementia complex /Î.
àíàòîìèè Perella, Carrieri P.B., Guarnaccia D., Ì. Soscia // J. Neurol. – 1992. – Vol. 239. – P. 387–388.
304. Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy./ Finsterer J., Schwerer Â., Bittner R.E., Mamoli B. // Clin Neuropathol. – 1999. – Vol 18, ¹ 1. –Ð. 31-36.
ÊÃÌÓ 305. Cerebrospinal fluid filtration in a case of schizophrenia related to “subclinical” Borna disease virus encephalitis / Bechter Ê., Herzog S., Schreiner V. et al. // Psychiatry, Psychoneuroimmunology, and Viruses / Ed. N. Muller. –Wien: Springer, 1999. –Ð. 19-35.
306. Cerebrospinal fluid filtration in multiple sclerosis in patients as an experimental therapeutic approach / Haas J., Sailer M., Diizel E. et al.
//J Neuroimmunol. – Suppl 1995. – Vol. 1. –Ð.37.
307. Cerebrospinal fluid insulin–like growth factor–1, insulin growth factor binding protein–2 or nitric oxide are not increased in MS or ALST / Ñ. Pirttila, S. Vanhatalo, U. Turpeinen, R. Riikonen // Acta Neurologica Scandinavica. – 2004. – Vol. 109, ¹ 5. – Ð. 337–341.
168 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 308. Cerebrospinal fluid levels of alpha–tocopherol in amyotrophic lateral sclerosis / F. De Bustos, F.J. Jimenez–Jimenez, J.A. Molina et al.
// J. Neural. Transm. – 1998. – Vol. 105, ¹ 6–7. – P. 703–708.
309. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis / T.
Ichiyama, H. Shoji, M. Kato et al. // European Journal of Pediatrics. – 2002. – Vol. 161, ¹ 3. – Ð. 133–137.
310. Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease / J.A. Molina, F.J. Jimenez–Jimenez, C. Vargas et al. // Acta Neurologica Scandinavica. – 2002. – Vol. 106, ¹ 6. – Ð. 347–350.
Êàôåäðà 311. Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy / O. Devinsky, S. Emoto, N.S.
Nadi, W.H. Theodore // Epilepsia. – 1993. – Vol. 34, ¹ 2. – P. 255–261.
312. Cerebrospinal fluid levels of oxytocin in Prader–Willi íîðìàëüíîé syndrome: a preliminary report / A. Martin, M. State, G.M. Anderson et al. // Biol. Psychiatry. – 1998. – Vol. 44, ¹ 12. – P. 1349–1352.
313. Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease / J.A. Molina, F.J. Jimenez–Jimenez, A. Hernanz et àíàòîìèè al. // Journal of Neural Transmission. – 2002. – Vol. 109, ¹ 7–8. – Ð.
1035–1044.
314. Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease / F.J. Jimenez–Jimenez, J.A. Molina, A. Hernanz et ÊÃÌÓ al. // Neurosci Lett. – 1999. – Vol. 271, ¹ 1. – P. 33–36.
315. Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis / C.A. Roca, T.P. Su, S. Elpern et al. // Biol.
Psychiatry. – 1999. – Vol. 46, ¹ 4. – P. 551–556.
316. Cerebrospinal fluid supports viability and proliferation of cortical cells in vitro, mirroring in vivo development / J.A. Miyan, M.
Zendah, F. Mashayekhi et al.// Cerebrospinal Fluid Research. – 2006. – Vol. 3, ¹2. – P. 1–7.
317. Cerebrospinal fluid-filtration reduces TNF-alpha in bacterial meningitis CSF / Pfausler Â., Grubwieser G., Bosch S. et al. // Eur J Neurol. –1995. –Vol. 2. –Ð.570–572.
318. Changes in plasma LRH during the normal menstrual cycle in women / A. Miyake, J. Kawamurra, T. Aono, K. Kurachi // Acta endocr.
– 1980. – Vol. 93, ¹ 3. – P. 257–263.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 319. Changes with aging of steroidal levels in the cerebrospinal fluid of women / K. Murakami, Ò. Nakagawa, M. Shozu et al. // Maturities. – 1999. – Vol. 33, ¹ 1. – P. 71–80.
320. Cholinergic augmentation of lymphocyte–mediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes / T.B. Strom, A.J. Sytkowkski, C.B. Carpenter et al. // Proc Natl Acad Sci USA. – 1974. – Vol. 71. – P. 1330–1333.
321. Chrousos G.P. The hypothalamic–pituitary–adrenal axis and immune–mediated inflammation / Chrousos G.P. // N Engl J Med. – 1995. – Vol. 332. – P. 1351–1362.
Êàôåäðà 322. Circadian rhythmicity of vasopressin levels in the cerebrospinal fluid of suprachiasmatic nucleus–lesioned and –grafted rats / K.E. Van Esseveldt, B.A. van der Geest, H. Duindam et al. // J.
Biol. Rhythms. – 1999. – Vol. 14, ¹ 1. – P. 28–36.
íîðìàëüíîé 323. Clemens J.A. Identification of prolactin in cerebrospinal fluid / Clemens J.A., Â. Sawyer // Exptl Brain Res. – 1974. – Vol. 21, ¹ 4. – P.
399–402.
324. CNS immune privilege: hiding in plain sight / M.J. Carson, àíàòîìèè J..M. Doose, B. Melchior et al. // Immunol Rev. – 2006. – Vol. 213. – P.
48–65.
325. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia / H. Tohgi, ÊÃÌÓ Ò. Abe, S. Takahashi et al. // Neurosci Lett. – 1992. – Vol. 141, ¹ 1. – P. 9–12.
326. Concept and therapeutic effiency of CSF fltration in acute cases of Guillain-Barre syndrome / Wollinsky K.H., Hulser P.-J., Brinkmeier H. et al. // Symposium “CSF filtration – a new concept for the treatment of neurological diseases with autoimmune pathogenesis”.
–Magdeburg, 1994. – Ð. 142-144.
327. Continuous filtration of cerebrospinal fluid (CSF-Filtration) in fulminant bacterial meningitis / Kalischewski P., D. Schneider, Kühn H.-J. et al. // A New adjuvant Therapeutic Strategy In Anesthesia, Pain, Intensive Care and Emergency Medicine, A. Gullo (eds). –Trieste, Foliazza Editore, 1996. –Ð. 627-638.
328. Correlation between concentrations of calcitonin and parathyroid hormone in cerebrospinal fluid of man / S. Balabanov, V.
170 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ Tollner, H. Richter et al. // Acta endocrinol. – 1983. – Vol. 103, ¹ 25. – P. 133–135.
329. Corticotropin–releasing factor (CRF) and interleukin–1 (IL–l) receptors in the brain–pituitary–immune axis / E.B. De Souza, E.L.
Webster, D.E. Grigoriadis et al. // Psychopharmacol Bull. – 1989. – Vol.
25. – P. 299–305.
330. CSF insulin–like growth factor–1 in infantile neuronal ceroid lipofuscinosis / R. Riikonen, S.L. Vanhanen, J. Tynela et al. // Neurology. – 2000. – Vol. 54, ¹ 9. – P. 1828–1832.
331. CSF monoamines, age and impulsivity in wild grivet monkeys Êàôåäðà (Cerco–pithecus aethiops) / L.A. Fairbanks, M.B. Fontenot, J.E.
Phillips–Conroy et al. // Brain Behav Evol. – 1999. – Vol. 53, ¹ 5 – 6. – P. 305–312.
332. Cushing H. Concerning the secretion of the infundibular lobe íîðìàëüíîé of the pituitary body and its presence in the cerebrospinal fluid / Í.
Cushing, Å. Goetsch // Am. J. Physiol. – 1910. – Vol. 27. – P. 60–86.
333. Dachel R. CSF filtration in the hronic inflammatory demyelinating polyneuropathy / Dachel R., Knietsch A. //Symposium àíàòîìèè “CSF filtration – a new concept for the treatment of neurological diseases with autoimmune pathogenesis”. – Magdeburg, 1994.
334. Davidsson P. Peptide mapping of proteins in cerebrospinal £uid utilizing a rapid preparative two–dimensional electrophoretic ÊÃÌÓ procedure and matrix–assisted laser desorption/ionization mass spectrometry / P. Davidsson, C.L. Nilsson // Biochimica et Biophysica Acta. – 1999. – Vol. 1473. – P. 391–399.
335. Davson H. The blood–brain barrier / H. Davson // J. Physiol. – 1976. – Vol. 255. – P. 1–28.
336. Dean A. Seehusen. Cerebrospinal fluid analisis / Dean A.
Seehusen, Mark M. Reeves, Demitri A. Fomin // Am. Fam. Physician. – 2003. – Vol. 68. – P. 1103–1108.
337. Deane R. Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin–bound and free iron into the rat brain / R. Deane, W. Zheng, B.V. Zlokovic // Journal of Neurochemistry. – 2004. – Vol. 88. – P. 813–820.
338. Decreased cerebrospinal fluid levels of b–endorphin and ACTH in children with infantile spasms / S. Nagamitsu, T. Matsuishi, Y.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ Yamashita et al. // Journal of Neural Transmission. – 2001. – Vol. 108, ¹ 3. – P. 363–371.
339. Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease / F. Michele, P. Longone, E. Romeo et al. // Neurological Sciences. – 2003. – Vol. 24, ¹ 3. – Ð. 172–173.
340. Desiderio D. M. Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid / D.Ì. Desiderio // J. Chromatogr  Biomed Sci Appl. – 1999. – Vol.
731, ¹ 1. – P. 3–22.
341. Determination of free and total (free plus protein–bound) Êàôåäðà melatonin in plasma and cerebrospinal fluid by high–performance liquid chromatography with fluorescence detection / V. Rizzo, C. Porta, M.
Moroni et al. // Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. – 2002. – Vol. 774, ¹ 1. – Ð. 17–24.
íîðìàëüíîé 342. Differences in immune cell invasion into the cerebrospinal fluid and brain parenchyma during cerebral infusion of interleukin–1 / B. Schoning, P. Elepfandt, N. Daberkow et al. // Neurol Sci. – 2002. – Vol. 23. – P. 211–218.
àíàòîìèè 343. Direct isolation of human central nervous system stem cells / N. Uchida, D.W. Buck, D. He et al. // PNAS. – 2000. – Vol. 97, ¹ 26. – P.14720 – 14725.
344. Dixon W. Pituitary secretion / W.Dixon // J. Physiol. – 1923. – ÊÃÌÓ Vol. 57. – P. 129–138.
345. Does neonatal cerebrospinal fluid absorption occur via arachnoid projections or extracranial lymphatics? / Ñ. Papaiconomou, R.
Bozanovic–Sosic, À. Zakharov, Ì. Johnston // Amer. J. Physiol. – 2002. – Vol. 283, ¹ 4, ÷. 2. – Ð. R869–R876.
346. Dose–effects of recombinant human interleukin–6 on pituitary hormone secretion and energy expenditure / Ñ. Tsigos, D.A.
Papanicolaou, R. Defensor et al. // Neuroendocrinology. – 1997. – Vol.
66. – P. 54–62.
347. Dreder C.D. TNF immunoreactive innervation in the mouse brain / C.D. Dreder, Ñ.Â.Saper // Soc. Neirosci Abstr. – 1988. – Vol.
144. – P. 1280.
348. Duque M. C. Immunophenotyping of blood and cerebrospinal fluid leukocytes in dogs / M. C. Duque. – 2001. – 55 p.
172 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 349. Dynamic properties of lymphatic pathways for the absorption of cerebrospinal fluid / T. Brinker, W. Ledemann, D. Berens von Rautenfeld et al. // Acta Neuropathol. – 1997. – Vol 94. – P. 493–498.
350. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels / Jiang–Ning Zhou, Rong–Yu Liu, Wouter Kamphorst et al. // Journal of Pineal Research. – 2003. – Vol. 35, ¹ 2. – Ð. 125–130.
351. Effects of physical activity and acupuncture on calcitonin gene–related peptide immunoreactivity in different parts of the rat brain and in cerebrospinal fluid, serum and urine / Y. Wyon, M. Hammar, E.
Êàôåäðà Theodorsson, T. Lundeberg // Acta Physiol Scand. – 1998. – Vol. 162, ¹ 4. – P. 517–522.
352. Egashira Ò. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM–III–R psychiatric íîðìàëüíîé diagnoses / Ò. Egashira, F. Takayama, Y.Yamanaka // Biol. Psychiatry.
– 1999. – Vol. 46, ¹ 6. – P. 821–826.
353. Egashira Ò. Changes in monoamine metabolites concentrations in rat cerebrospinal fluid after acute and long–term administration of a àíàòîìèè selective serotonin reuptake inhibitor, trazodone / Ò. Egashira, Takayama F., Yamanaka Y. // Pharmacol Res. – 1999. – Vol. 40, ¹ 6. – P. 503–508.
354. Elevated CSF prostaglandin E2 levels in patients with ÊÃÌÓ probable AD / T.J. Montine, K.R. Sidell, B.C. Crews et al. // Neurology.
– 1999. – Vol. 55, ¹ 7. – P. 1495–1498.
355. Elevated interleukin–6 levels in cerebrospinal fluid of vascular dementia patients / K. Wada–Isoe, Y. Wakutani, K. Urakami, K.
Nakashima // Acta Neurologica Scandinavica. – 2004. – Vol. 110, ¹ 2.
– Ð. 124–127.
356. Engelborghs S. Amino acids and biogenic amines in cerebrospinal fluid of patients with parkinson's disease / S. Engelborghs, Marescau Â, Ð.Ð. De Deyn // Neurochemical Research. – 2003. – Vol.
28, ¹ 8. – Ð. 1145–1150.
357. Establishment and properties of neural stem cell clones:
plasticity in vitro and in vivo / A.L. Vescovi, E.Y. Snyder // Brain Pathol. – 1999. – Vol. 9, ¹ 3. – P.569 – 598.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 358. Etude d’un liquide cephalo-rachidien artificiel / Lataste X., Vandendriessche M., Castel J.P., Cohadon F. //Neurochirurgie (Paris). – 1980. – Vol. 26, ¹ 3. –Ð. 201-220.
359. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non–human primates and other mammalian species / M. Johnston, A. Zakharov, C. Papaiconomou et al.
// Cerebrospinal fluid research. – 2004. – Vol. 1, ¹2. – P. 1 – 13.
360. Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of Influenza–associated encephalopathy of children / H. Kawashima, T. Morishima, T. Togashi et al. // Neurochemical Êàôåäðà Research. – 2004. – Vol. 29, ¹ 8. – Ð. 1537–1540.
361. Fabian R. H. Intraneuronal Ig G in the central nervous system / R. Í. Fabian, G. Petroff // Neurol. – 1987. – Vol.37, ¹ 9. – P. 1780–1784.
362. Fabian R. H. Uptake of antineuronal Ig M by CNS neurons:
íîðìàëüíîé comparison with antineuronal Ig G / R. Í. Fabian // Neurol. – 1990. – Vol.40, ¹ 5. – P. 419–422.
363. Filtration of cerebrospinal fluid for acute demyelinating neuropathy in systemic lupus erythematosus / Stahl H.-D., Kalischewski àíàòîìèè P., Orda C. et al. //Clin Rheanimatol. – 2000. – Vol. 19 – Ð. 61-63.
364. Filtration of cere-brospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barre syndrome)/ Wollinsky K.H., Hulser P.J., Brinkmeier H. et al. // Ann Med Intern –1994. – ÊÃÌÓ Vol.145. –Ð. 451-458.
365. Finsterer J. Cerebrospinal fluid filtration in amyotrophic lateral sclerosis / Finsterer J., Mamoli Â. // Eur J Neurol. – 1999. – Vol. 65. – Ð. 597-600.
366. Finsterer J. Liquorpheresis (CSF filtration) in familial amyotrophic lateral sclerosis. / Finsterer J., Mamoli Â.//Spinal Cord. – 1999. – Vol 37, ¹8. – Ð.592-594.
367. Fliedner T.M. The stem cell system of hematopoiesis:
physiological and pathophysiological concepts/ T.M. Fliedner, W.Nothdurft, W. Calvo //Verh Dtsch Ges Pathol.– 1990.–Vol. 74.–P.1–18.
368. Friede R. L. A new approach for determining the volume of cerebral extra–cellular fluid and demonstration of its communication with CSF / R.L. Friede, Kuo Hao Hu // J. Physiol. – 1971. – Vol. 218. – P. 477–493.
174 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 369. Gerner M. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patient / Ì. Gerner, Yamada T. // Brain res. – 1982. – Vol. 238, ¹ 1. – P. 298–302.
370. Gillette S. Changes in thymic estrogen receptor expression following orchidectomy / S. Gillette, R. Gillette // Cell Immunol. – 1979. – Vol. 42. –P. 194–196.
371. Gonadotropin–releasing hormone secretion into third–ventricle cerebrospinal fluid of cattle: correspondence with the tonic and surge release of luteinizing hormone and its tonic inhibition by suckling and neuropeptide Y / O.S. Gazal, L.S. Leshin, R.L. Stanko et al. // Biol.
Êàôåäðà Reprod. – 1998. – Vol. 59, ¹ 3. – P. 676–683.
372. Grimes M.A. Cerebrospinal fluid concentrations of tryptophan and 5–hydroxyindoleacetic acid in Macaca mulatta: diurnal variations and response to chronic changes in dietary protein intake / Ì.À. Grimes, íîðìàëüíîé Cameron J.L., Fernstrom J.D. // Neuro–chem Res. – 2000. – Vol. 25, ¹ 3. – P. 413–422.
373. Guidelines on routine cerebrospinal uid analysis. Report from an EFNS task force / F. Deisenhammer, A. Bartos, R. Egg et al. // àíàòîìèè European Journal of Neurology. – 2006. – Vol. 13. – P. 913–922.
374. Hefco V. The modulator role of the hypothalamic paraventricular nucleus of immune responsiveness / Hefco V., Olariu V.
A., À. Hevko // Brain Behav. Immunol. – 2004. – Vol. 18, ¹ 2. – P.
ÊÃÌÓ 158–165.
375. Helderman J.H. Specific insulin binding site on T and B lymphocytes as a marker of cell activation / J.H. Helderman, T. Strom // Nature. – 1978. – Vol. 274. – P. 62–63.
376. Hepatocyte growth factor in cerebrospinal fluid in neurologic disease / Y. Tsuboi, K. Kakimoto, H. Akatsu et al. // Acta Neurologica Scandinavica. – 2002. – Vol. 106, ¹ 2. – Ð. 99–103.
377. Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between fcute bacterial and nonbacterial meningitis / F.
Nayeri, I. Nilsson, L. Hagberg et al. // J. Infect. Dis. – 2000. – Vol. 181, ¹ 6. – P. 2092–2094.
378. Herring P. The histological appearances of the mammalian pituitary body / Ð. Herring // Quart. J. Experim. Phisiol. - 1908. – Vol. 1, ¹ 5 – P. 121–159.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 379. Hiesland P. Mechanism of action: cyclosporin and prolactin– mediated control of immunity / P. Hiesland, P. Mekler // Prog. Allergy.
– 1986. – Vol. 38. – P. 239–246.
380. Hirai K. Cerebrospinal fluid somatostatin levels in febrile seizure and epilepsy in children / Ê. Hirai, Ò. Seki // Neuropeptides. – 2000. – Vol. 34, ¹ 1. – P. 18–24.
381. Hoff H. Untersuchungen uber die Becinflussung der Pituitrinsecretion durch Diuretica / Í. Hoff, Ð. Wermer // Klin.
Wochenschr. – 1927. – ¹ 5. – S. 25.
382. Holienberg M.D. Hormone receptors and membrane Êàôåäðà glycoproteins during in vitro transformation of lymphocytes / Holienberg M.D., Ð. Cuatrecasa –New York: Cold Spring Harbor Laboratory, 1974. – Ð.423–434.
383. Hulser P.J. Liquorpheresis eliminates blocking factors from íîðìàëüíîé cerebrospinal fluid in polyradiculoneuritis (Guillain-Barre syndrome) / Hulser P.J., Wietholter H., Wollinsky K.H. // Eur Arch Psychiat Clin Neurosci. –1991. –Vol. 241, ¹ 2. –Ð.69-72.
384. Human cerebrospinal fluid contains CD4+ memory T cells àíàòîìèè expressing gut– or skin–specific trafficking determinants: relevance for immunotherapy / P. Kivisakk, B. Tucky, T. Wei et al. // BMC Immunology. – 2006. – Vol. 7, ¹ 14. – P. 1–8.
385. Human chorionic gonadotrophin in CSF, not serum, predicts ÊÃÌÓ outcome in germinoma / Ò. Inamura, S. Nishio, K. Ikezaki, M. Fukui // J. Neurol. Neurosurg. Psychiatry. – 1999. – Vol. 66, ¹ 5. – P. 654–657.
386. Identification of beta–adrenoceptors during thymocyte ontogeny in mice / U. Singh, D.S. Millson, P.A. Smith et al. // Eur J lmmunol. – 1979. – Vol. 9. – P. 31–35.
387. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test / V. Lejon, D. Legros, M. Richer et al. // Tropical Medicine & International Health. – 2002. – Vol. 7, ¹ 8. – Ð. 685–692.
388. Ilzecka J. Brain–derived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients / Ilzecka J., Stelmasiak Z. // Neurological Sciences. – 2002. – Vol. 22, ¹ 6. – Ð. 473–474.
389. In situ histochemical localization of type I interleukin– 176 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse /E.T. Cunningham, E. Wada, D.B. Carter et al. // J. Neurosci. – 1992. – Vol.12. – P. 1101–1114.
390. In vitro studies of immunoregulation by substance P and somatostatin /A. Stanisz, R. Scicchitano, D. Payan et al. // Ann N Y Acad Sci. – 1987. – Vol. 496. – P. 217–225.
391. Increased cerebrospinal fluid cAMP levels in Alzheimer's disease / M. Martinez, E. Fernandez, A. Frank et al. // Brain Res. – 1999.
– Vol. 846, ¹ 2. – P. 265–267.
392. Increased hepatocyte growth factor level in cerebrospinal fluid Êàôåäðà in Alzheimer's disease / Y. Tsuboi, K. Kakimoto, M. Nakajima et al. // Acta Neurologica Scandinavica. – 2003. – Vol. 107, ¹ 2. – Ð. 81–86.
393. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression / Ñ. Kirkergaard, Faber J., Hummer L., Ð.
íîðìàëüíîé Rogowsci P. // Psychoneuroendocrinology. – 1979. – Vol. 4, ¹3. – P.
227–235.
394. Influence of CSF filtration on a new gliotoxic factor in cerebrospinal fluid from multiple sclerosis patients / Ò. Dobransky, àíàòîìèè Amouri R., Wollinsky K.H. et al. // Neuropsychiatrie. – 1995. –Vol. 9. – Ð. 89-93.
395. Insulin–like growth factor binding proteins in cerebrospinal fluid during human development and aging / P. M. Arnold, J.Y. Ma, ÊÃÌÓ B.A. Citron, B.W. Festoff // Biochem. Biophys. Res. Commun. – 1999.
– Vol. 264, ¹ 3. – P. 652–656.
396. Interaction of glucocorticoids with macrophages.
Indentification of glucocorticoid receptors in monocytes and macrophages / Z. Werb, R. Foley, A. Munck et al. // J. Exp Med. – 1978.
– Vol. 147. – P. 1684–1694.
397. Interactions among CNS, neuroendocrine and immune systems / R.M.A. Landmann, M. Wesp, R. Box. – Rome: Pythagora Press, 1989.
– P. 251–264.
398. Intracerebroventricular but not intravenous interleukin–1b induces widespread vascular–mediated leukocyte infiltration and immune signal mRNA expression followed by brain–wide glial activation / M.G. Proescholdt, S. Chakravarty, J. A. Foster et al. // Neuroscience. – 2002. – Vol. 112, ¹ 3. – Ð. 731–749.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 399. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats / K.F. Sjolund, A. Sollevi, M. Segerdahl, T.
Lundeberg // Anesth Analg. – 1997. – Vol. 85, ¹ 3. – P. 627–632.
400. Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients / G. Izquierdo, S. Angulo, J.M. Garcia–Moreno et al. // Acta Neurologica Scandinavica. – 2002. – Vol. 105, ¹ 3. – Ð. 158–163.
401. Investigation of cytokine (tumor necrosis factor–alpha, interleukin–6, interleukin–10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus Êàôåäðà erythematosus / K. Baraczka, K. Nekam, T. Pozsonyi et al. // European Journal of Neurology. – 2004. – Vol. 11, ¹ 1. – Ð. 37–42.
402. Johnston M. Possible role of the cavernous sinus veins in cerebrospinal fluid absorption / M. Johnston, D. Armstrong, L. Koh // íîðìàëüíîé Cerebrospinal fluid research. – 2007. – Vol. 4, ¹3. – P. 1 – 5.
403. Joseph S. Releasing hormones, LRF and TRF in the cerebrospinal fluid of the third ventricle / Joseph S., Sorrentino S., Sundberg D. // Brain–Endocrine Interaction. II. The ventricular system.
àíàòîìèè – 2nd internat. sympos. –Shizuoka, 1974, Basel, 1975. – P. 306–312.
404. Kabayashi H. Absorption of cerebrospinal fluid by ependimal cells of the median eminence / Kabayashi H. // Brain–Endocrine Interaction. II. The ventricular system. –2nd internat. sympos. –Shizuoka, ÊÃÌÓ 1974, Basel, 1975. – P. 109–122.
405. Kalin N.H. Cerebrospinal fluid corticotropin–releasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament / Kalin N.H., S.Å. Shelton, Davidson R.J. // Biol. Psychiatry. – 2000. – Vol. 47, ¹ 7. – P. 579–585.
406. Kamberi J.A. Effecys of melatonin and serotonin on the release of FSH and prolactin / Kamberi J.A., Mical R.S., Porter J. // Endocrinology. – 1971. – Vol. 88, ¹ 6. – P. 1288–1293.
407. Karplus J. Ueber die Beeinflussung der Hypophysentatigkeit durch die Erregung des Hypothalamus / Karplus J., Î. Peczenik // Pflugers Arch. – 1930. – Bd. 225. – S. 654–668.
408. Kauers U. The diagnostic validity of lysozyme activity in lumbal Cerebrospinal fluid and in serum / Kauers U., Â. Weisner // J.
Clin. and Clin. Biochem. – 1981. – Vol. 19, ¹ 8. – P. 726–727.
178 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 409. Kendall J. Etudes on the transport of hormones from the cerebrospinal fluid to hypothalamus and pituitary / Kendall J., Jacobs I., R. Kramer // Brain–Endocrine Interaction., Basel, 1972. – P. 342–349.
410. Kirschfink M., Rother S. CSF-filtration a new therapeutical concept /// Anaesthesia, Pain, Intensive Care and Emergency Medicine, A. Gullo (eds). –Milano, 1994. – Ð.577-586.
411. Kjellin T. Der gehal an Prolan in Liquor cerebrospinalis besonders bei eccentieller Hypertonie /Ò. Kjellin, Å. Kylin Å. // Deutsches Archfur Klinische medicin. – 1934. – Vol. 176, ¹ 6. – Ð.
683–689.
Êàôåäðà 412. Kleine T.O. Molecular heterogeneity, detected by two electrophoretic micro procedures, of IgG in human cerebrospinal fluid (CSF) /Ò.Î. Kleine, Ò. Damm Ò. // Analytical and Bioanalytical Chemistry. – 2003. – Vol. 375, ¹ 8. – Ð. 1000–1005.
íîðìàëüíîé 413. Knowles F. Cerebrospinal fluid and endocrine regulation / Knowles F. // Proc. internat. Sympos. – Bratislava, 1974. – P. 11–28.
414. Konagaya Y. Abnormality of hypothalamic dopaminergic system in neuro–degenerative diseases–evaluation of alpha– àíàòîìèè melanocyte–stimulating hormone–like immunoreactivity in Cerebrospinal fluid / Konagaya Y., Ì. Konagaya // Rinsho Shinkeigaku.
– 1991. – Vol. 31, ¹ 8. – P. 821–825.
415. Kontinuierliche liquorfiltration bei foudroyanter bakterieller ÊÃÌÓ meningitis / Kalischewski P., Berrouschot J., Kohn H.-J. et al. //Akta Neurol. –1996. –Vol. 23. –Ð. 61.
416. Kordon C. Role of neurotransmitters in the secretion of pituitary gonadotropins and prolactin / Ñ. Kordon C. //Control of ovulation. – London, 1978. – P. 21–28.
417. Kratochvil A. Correlations Between the cerebrospinal fluid surface tension value and 1. Concentration of total proteins 2. Number of cell elements / À. Kratochvil, Å. Hrncir E. // Gen. Phisiol. And Biophis. – 2002. – Vol. 21, ¹ 1. – P. 47–53.
418. Krubitzer L. Nature versus nurture revisited: an old idea with a new twist / L. Krubitzer, D. M. Kahn // Prog Neurobiol. – 2003. – Vol.
70. – P. 33–52.
419. Kwon C.H. Pten regulates neuronal arborization and social interaction in mice / Ñ.Í. Kwon // Neuron. – 2006. – vol. 50. – P. 377–388.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 420. Lack of correlation between cerebrospinal fluid thyrotropin– releasing hormone (TRH) and TRH–stimulated thyroid–stimulating hormone in patients with depression / M.A. Frye, R.T. Dunn, K.A. Gary et al. // Biol Psychiatry. – 1999. – Vol. 45, ¹ 8. – P. 1049–1052.
421. Landt M. Leptin in cerebrospinal Fluid from children:
correlation with plasma leptin, sexual dimorphism, and lack of protein binding / Ì. Landt, Parvin C.A., Ì. Wong M. // Clin. Chem. – 2000. – Vol. 46, ¹ 6. – P. 854–858.
422. Lefvert A.KIg G production with the central nervous system, a critical review of proposed formulae / À.Ê. Lefvert, Link H. // Ann.
Êàôåäðà neurol. – 1984. – Vol.16, ¹ 5. – P. 13–20.
423. Liquorpherese – ein neuer ansatz in der therapie des Guillain Barre syndroms / Hulser P.J., Wollinsky K.H., Weindler M. et al. //Verh Dtsch Ges Neurol. –1990. –Vol. 6. –Ð. 620-621.
íîðìàëüíîé 424. Liquorpherese bei 10 patienten mit multipler skleros./ Wollinsky K.H., Hulser P.J., Mauch E. et al. // Verb Dtsch Ges Neurol.
–1992. –Vol. 7. –Ð. 444-445.
425. Liquor-pheresis (CSF-Filtration) an effective treatment in àíàòîìèè acute and chronic severe autoimmune polyradiculoneuritis (Guillain Barre syndrome)/ Wollinsky K.H., Weindler M., Hulser P.J. et al. // Eur Arch Psych Clin Neurosci. – 1991. –Vol. 241. – Ð. 73-76.
426. Liu Guo–qing. Zhang Xiao–rong. Zhao You–zhang // ÊÃÌÓ Zhongswo shouyi xuebao = Chin. J. Vet. Sci. – 2002. – Vol. 22. ¹ 3. – Ñ. 265–266.
427. Liu Z. A high–recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid / Liu Z., Ì. Welin, Bragee B. F. // Nyberg Peptides. – 2000. – Vol. 21, ¹ 6. – P. 853–860.
428. Low calcitonin gene–related, peptide–like immunoreactivity in cerebrospinal fluid from chronic pain patients / C. Lindh, Z. Liu, M.
Welin et al. // Neuropeptides. – 1999. – Vol. 33, ¹ 6. – P. 517–521.
429. Luteinizing hormone (LH)–releasing hormone in third ventricular cerebrospinal fluid of the ewe: correlation with LH pulses and the LH surge / D.C. Skinner, Â. Malpaux, Â. Delaleu, A. Caraty // Endocrinology. – 1995. – Vol. 136, ¹ 8. – P. 3230–3237.
180 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 430. Lymphocyte blast transformation. Demonstration of adrenergic receptors in human peripheral lymphocytes / J.W. Hadden, E.M. Hadden, E.J. Middleton et al. // Cell Immunol. – 1970. – Vol. 1. – P. 583–595.
431. Lyson K. The effect of interleukin–6 on pituitary hormone release in vivo and in vitro / Ê. Lyson K., S.Ì. McCann // Neuroendocrinology. – 1991. – Vol. 54. – P. 262–266.
432. Macrophages and neurodegeneration / J.J. Hendriks, C.E.
Teunissen, H.E. Vries et al. // Brain Res Brain Res Rev. – 2005. – Vol.
48. – P. 185–195.
Êàôåäðà 433. Manfredi P.L. CSF filtration is an effective treatment of Guillain-Barre syndrome A randomized clinical trial / Manfredi P.L.
//Neurology. – 2002. – Vol 58. – Ð. 988–989.
434. Marquette C. IL–1 beta, TNF alpha and IL–6 inductions in the íîðìàëüíîé rat brain after portal–body irradiation: role of vagal afferents / Ñ.
Marquette // Int. J. Radiat. Biol. – 2003. – Vol. 79, ¹ 10. – P. 777–785.
435. Martin S.B. Tumor necrosus factor a (TNF) in neuroimmunology / S.Â. Martin, Tracey K.J. // Adv Neuroimmunol. – àíàòîìèè 1992. – Vol. 2. – P. 125–138.
436. Martinez M. Changes cerebrospinal fluid cAMP levels in Alzheimer's disease patients / Ì. Martinez // Brain Res. – 1998. – Vol.
834, ¹ 2. – P. 223–242.
ÊÃÌÓ 437. Measuring HIV–1 RNA and interferon–alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex / A. Krivine, G. Force, J. Servan et al. // J.
Neurovirol. – 1999. – Vol. 5, ¹ 5. – P. 500 – 506.
438. Melrose Patricia Ann. Anatomical and hormonal studies investigating a possible role for cerebrospinal fluid in neuroendocrine communication associated with the control of reproduction (horse) / Melrose Patricia Ann //Dissertation Abstracts International. – 1984. – Vol. 44, ¹ 6. – P. 1742.
439. Mess B. Effects of intracerebral serotonin administration on the function of the thyrotrophic hormone (TSH) – thyreoid system / Â.
Mess, Peter L. // Endocrinol. Exp. – Vol. 8, ¹ 3. – P. 160–168.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 440. Miyake A. Luteinizing hormone–releasing hormone in cerebrospinal fluid of women/ À. Miyake, Kurachi Í., Kawamurra J. // Endocr. Jap. – 1980. – Vol. 27, ¹ 1. – P. 117–119.
441. Modulation of inflammation and immunity by cyclic AMP Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions / H.R. Bourne, L.M. Lichtenstein, K.L. Melmon et al. // Science. – 1974. – Vol. 184. – P. 19–28.
442. Molecular mechanisms of cerebrospinal fluid production / P.
D. Brown, S. L. Davies, T. Speake et al. // Neuroscience. – 2004. – Vol.
129, 4. – P. 957–970.
Êàôåäðà 443. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease / C.E. Johanson, J.A. Duncan, P.M. Klinge et al. // Cerebrospinal fluid research. – 2008. – Vol. 5, 10. – P. 1 – 32.
444. Nathanson J.A. Immunological function of the blood– íîðìàëüíîé cerbrospinal fluid barrier / Nathanson J.A., Chun L.Y. // Proc. Natl.
Acad. Sci. USA. – 1989. – Vol. 86, ¹ 3. – P. 1684–1688.
445. Negro M.F. Sur La fonction et L’aktion du liquide cephalo– nachidien / Negro M.F.// Revue Neurologigi. – 1931. – Vol. 11, ¹ 6. – àíàòîìèè Ð. 790–794.
446. Nerenbery S.T. Cerebrospinal fluid Ig G, Ig A, Ig M, Ig D and Ig E. Levels in central nervous system disoders / S.Ò. Nerenbery, R. Prasad, M.E. Kothman // Neurology. – 1978. – Vol.28, ¹ 10. – P. 988–990.
ÊÃÌÓ 447. Neuroendocrine modulation of immune system / G. Dan, S.B.
Lall // Indian Journal of Pharmacology. – 1998. – Vol. 30. – P.129–140.
448. Neuropeptide Y and corticotropin–releasing hormone in CSF mark response to antidepressive treatment with citalopram / G. Nikisch, H. Agren, C.B. Eap et al. // The International Journal of Neuropsychopharmacology. – 2005. – Vol. 8, ¹ 3. – P. 403–410.
449. Ojeda S. Central effect of prostaglandin E1 (PGE1) on prolactin release / S. Ojeda, Ð. Harnes, S. McConn // Endocrinology. – 1974. – Vol. 95, ¹ 2. – P. 613– 450. Ottaway C.A. Vasoactive intestinal peptide and immune function // Ottaway C.A. / Psychoneuroimmunology. –2 ed. – New York: Academic Press Inc., 1991. – P. 225–262.
451. Pardridge W.M. The blood–brain barrier: cellular and molecular biology/ Pardridge W.M.. –New York: Raven Press, 1993. – 430 p.
182 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 452. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease / M.A. Raskind, E.R. Peskind, C. Holmes, D.S. Goldstein // Biol.
Psychiatry. – 1999. – Vol. 46, ¹ 6. – P. 756–765.
453. Pavel S. Presence of relative high concentrations of arginine vasotocin in the cerebrospinal fluid of newborns and infants / S. Pavel // J Clin. Endocr. – 1980. – Vol. 50, ¹ 2. – P. 271–273.
454. Peptide repertoire of human cerebrospinal uid: novel proteolytic fragments of neuroendocrine proteins / M. Stark, O.
Danielsson, W.J. Grifths et al. // Journal of Chromatography B. – 2001.
Êàôåäðà – Vol. 754. – P. 357 –367.
455. Permeability of the blood–cerebrospinal fluid barrier to plasma proteins during fetal and perinatal life / À. Adinolfi, S.Å. Beck, S.A.
Haddad, M.H. Seller // Nature. – 1976. – Vol.259. – P. 140.
íîðìàëüíîé 456. Plasma and cerebrospinal fluid amino acids in epileptic patients / S. Rainesalo, T. Keranen, J. Palmio et al. // Neurochemical Research. – 2004. – Vol. 29, ¹ 1. – Ð. 319–324.
457. Plasma and cerebrospinal fluid concentration of neuropeptide àíàòîìèè Y, serotonin, and catechol–amines in patients under propofol or isoflurane anesthesia / E. Grouzmann, A. Borgeat, M. Fathi et al. // Can.
J. Physiol. Pharmacol. – 2000. – Vol. 78, ¹ 2. – P. 100–107.
458. Podell M. Cerebrospinal fluid gamma–aminobutyric acid and ÊÃÌÓ glutamate values in patients with epilepsy / Ì. Podell, Hadjiconstantinou Ì. // Am. J. Vet. Res. – 1997. – Vol. 58, ¹ 5. – P.
451–456.
459. Porter J. Role of biogenic amines and cerebrospinal fluid in the neurovascular transmittal of hypophysotrophic substances / Porter J., Kamberi I., Ondo J. // Brain–Endocrine Interaction. –Basel, 1972. – P.
245–253.
460. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica / H. Brisby, K. Olmarker, K.
Larsson et al. // European Spine Journal. – 2002. – Vol. 11, ¹ 1. – Ð.
62–66.
461. Prolactin receptor on human lymphocytes and their modulation by cyclosporin / Russell D.H., Matrision L., R. Kibler R. et al. // Biochem Biophys Res Commun. – 1984. – Vol.121. – P. 899–906.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 462. Pro–opiocortin peptides in rat Cerebrospinal fluid / S. Jackson, S. Kiser, R. Corder, P.J. Lowry // Regul Pept. – 1985. – Vol. 11, ¹ 2. – P. 159–171.
463. Puri C.P. Bioactive luteinizing hormone in the plasma and cerebrospinal fluid of female rhesus monkeys / Ñ.Ð. Puri, Puri V., Anand Kumar Ò.Ñ. // J. Med. Primatol. – 1980. – Vol. 9, ¹ 1 – 2. – P. 39–49.
464. Receptors for interleukin–1 (alpha and beta) in mouse brain:
mapping and neuronal localization in hippocampus / E. Ban, G. Milon, N. Prudhomme et al. // Neuroscience. – 1991. – Vol. 43. – P. 21–30.
465. Richman D.P. Nicotinic acetylcholine receptor evidence for a Êàôåäðà functionally distinct receptor on human lymphocytes / D.P. Richman, B.G.
Arnason // Proc Natl Acad Sci USA. – 1979. – Vol. 76. – P. 4632–4635.
466. Riikonen R. Levels of cerebrospinal fluid nerve–growth factor differ in infantile autism and Rett syndrome / R. Riikonen, R. Vanhala íîðìàëüíîé //Developmental Medicine and Child Neurology. – 1999. – Vol. 41, ¹ 3. – P.148 – 152.
467. Rodriquez E. Morphological and functional relationships between the hypothalamo–neurophisical system and cerebrospinal fluid / àíàòîìèè Å. Rodriquez // Aspects of neuroendocrinology. V. Internat. Sympos. on neurosecretion. (eds. W. Bargman, B. Scharrer). – Berlin – N.Y., 1970.
– P. 352–365.
468. Rosler N. Intra vital lumbar and post mortem ventricular ÊÃÌÓ cerebrospinal fluid immunoreactive interleukin–6 in Alzheimer's disease patients / Rosler N., Wichart I., Ê.À. Jellinger // Acta Neurologica Scandinavica. – 2001. – Vol. 103, ¹ 2. – P. 126–130.
469. Rossi S. Rapid quantification of the d–opioid receptor selective enkephalin DPDPE in canine cerebrospinal fluid by liquid chromatography–mass spectrometry / S. Rossi, Yaksh T. // Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. – 2002. – Vol. 772, ¹ 1. – Ð. 73–79.
470. Rother S. Filtration of liquor cerebrospinalis (CSF-filtration) technical concept and filter performance under in vitro conditions / Rother S., Knoblauch K.D., Kirschfink M.. //Neuropsychology. –1995.
–Vol. 9. –Ð. 82-85.
471. Sagen J. Adrenal Medullary Transplants Increase Spinal Cord Cerebrospinal Fluid Catecholamine Levels and Reduce Pain Sensitivity / 184 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ Sagen J., Kemmler J.E., Í. Wang // The Journal of Neurophysiology. – 2001. – Vol. 85, ¹ 4. – Ð. 1788-1792.
472. Samuel S. Compartmentation in amino acid transport across the blood brain barrier / S. Samuel, S. À. Schwartz // Neurochem res. – 1981. – Vol.6. – P. 755–759.
473. Sass J.O. Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroid–lipofuscinosis / Sass J.O., Skladal D., Ì. Brunner–Krainz // Metab Brain Dis. – 1999. – Vol. 14, ¹ 1. – P.
67–70.
474. Scott D. The ventricular system in neuroendocrine Êàôåäðà mechanisms/ Scott D., Dudley G., Ê. Knigge // Cell and Tissue res. – 1974. – Vol. 154, ¹ 1. – P. 1–16.
475. Scott Th. F. Pattern and concentration of Ig G in cerebrospinal fluid in neurosarcoidosis / Scott Th. F., À.R. Seay A.R., Goust G.M. // íîðìàëüíîé Neurol. – 1989. – Vol.39. – P. 1637–1639.
476. Semenenia I.N. Changes in the prolactin content of the cerebrospinal fluid and blood serum in rabbits in dynamic hyperthermia induced by Freund's complete adjuvant / Semenenia I.N., Gurin A.V. // àíàòîìèè Zh Evol Biokhim Fiziol. – 1998. – Vol. 34, ¹ 2. – P. 270–272.
477. Serial CSF corticotropin–releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder / D.G. Baker, S.A. West, W.E. Nicholson et al. // Am. J.
ÊÃÌÓ Psychiatry. – 1999. – Vol 156, ¹ 4. – Ð. 585–588.
478. Serotonin in cisternal cerebrospinal fluid of rhesus monkeys:
basal levels and effects of sertraline administration / G.M. Anderson, A.J. Bennett, K.P. Weld et al. // Psychopharmacology. – 2002. – Vol.
161, ¹ 1. – Ð. 95–99.
479. Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers / A. Rousseau, S. Petren, J.
Plannthin et al. // J. Neural. Transm. – 1999. – Vol. 106, ¹ 9 – 10. – P.
883–888.
480. Sharief M.K. Intrathecal synthesis of Ig M in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation / Ì.Ê. Sharief, Keir G., Thompson E.J. // J.
Neurol. Sci. – 1990. – Vol. 96. – P. 131–142.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 481. Shuller E. Central nervous system Ig G synthesis in multiple sclerosis. Application of a new formula / Shuller E., Sagar H.J. //Acta Neurol. Scand. – 1983. – Vol.67, ¹ 6. – P. 365–371.
482. Simultaneous assay of prostaglandins and thromboxane in the cerebrospinal fluid by gas chromatography–mass spectrometry–selected ion monitoring / Ò. Obata, Ò. Nagakura, H. Maeda et al. // J. Chromatogr.
Â. Biomed. Sci. Appl. – 1999. – Vol. 731, ¹ 1. – P. 73–81.
483. Skinner D.C. Does gonadotropin–releasing hormone in the cerebrospinal fluid modulate luteinizing hormone release / Skinner D.C., À. Caraty A., Evans N.P. // Neuro–endocrinology. – 1998. – Vol. 67, ¹ Êàôåäðà 1. – P. 37–44.
484. Speake T. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus / T. Speake, L.J. Freeman, P.D. Brown // Biochimica et Biophysica Acta. – 2003. – Vol. 1609. – P. 80 – 86.
íîðìàëüíîé 485. Specific nonopiate receptor for beta endorphins / E. Hazum, K.J. Chang, P. Cuatrecasas // Science. – 1979. – Vol. 205. – P. 1033– 1035.
486. Spinal–fluid lisozyme in the diagnosis of the central nervous àíàòîìèè system tumors / Newman I., À. Cacatian, Josephson A.S., À. Tsang A. // Lancet. – 1974. – P. 756.
487. Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: a ventricular CSF study / O. M. Debus, ÊÃÌÓ A. Lerchl, H. W. Bothe et al. // Journal of Pineal Research. – 2002. – Vol. 33, ¹ 4. – Ð. 213–217.
488. Sterba G. Cerbrospinal fluid and hormones / Sterba G. // Ependima and neurohormonal regulation: Proc. Internat. Symposium. – Bratislava., 1974. – P. 143–173.
489. Streptococcal meningitis effect of CSF filtration on inflammation and neuronal damage / Schmidt H., Stuertz Ê., Trostdorf F. et al. //J Neurol. –1999. –Vol. 246. –Ð. 1063–1068.
490. Stumpf W. Estrogen–neurons and. estrogen–neuron systems in the periventricular brain / Stumpf W. // Amer. J. Anat. – 1970. – Vol.
129, ¹ 2. – P. 207–218.
491. Substance P recognition by a subset of human T lymphocyte / D. Payan, D. Brewster, A. Missirian–Bastian et al. // J. Clin. Invest. – 1984. – Vol. 74. – P. 1532–1539.
186 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 492. Suzuki T. Transient elevation of interleukin–6 levels at the initial stage of meningitis in children /Ò. Suzuki, À. Ishiguro, Ò. Shimbo // Clinical and Experimental Immunology. – 2003. – Vol. 131, ¹ 3. – Ð.
484–489.
493. Tabira T. Multiple sclerosis cerebrospinal fluid / Tabira T., Webster H. de F., S. Í. Wray S.H. // Neurocem. – 1976. – Vol. 59, ¹ 1.
– Ð. 1386 – 1390.
494. Tesch M. Liquorfiltration beim Stiff – Man – Syndrom / Tabira T., Webster H. de F., S.Í. Wray S.H. //Neurol Rehabil. – 1998.
– ¹ 4. – Ð. 80-82.
Êàôåäðà 495. The impact of lumbar cerebrospinal fluid filtration on lumbar and ventricular CSF in pneumococcal meningitis / Â. Pfausler, Stadlbaur D., Herold M., Schmutzhard E. // Neurol Infect Epidemiol. – 1997. – Vol.2. – Ð. 173-175.
íîðìàëüíîé 496. The involvement of the blood–brain and the blood– cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain / D. Kurrimbux, Z. Gaffen, C.L. Farrell et al. // Neuroscience. – 2004. – Vol. 123, ¹ 2. – Ð. 527–536.
àíàòîìèè 497. The peptides of the immimî–neuro–endocrine system /Ì.Aim //European J. Histochemistry. – 1993. – Vol. 7. – P. 10 – 12.
498. The role of monoamines in the control of gonado–tropin and prolactin secretion / S. McCann, Ð. Kalra P., Donoso A., Bishop W. et ÊÃÌÓ al. // Brain–Endocrine Interaction. – Basel, 1972. – P. 224–235.
499. The some immunobiological properties of a cerebrospinal fluid: cytotoxic, cytolytic effects, use of a cerebrospinal fluid as a nutrient medium for the cultivation of cells and tissues / Ì.À.
Kriventsov, Tkach V.V. (jr.), Bessalova Ye.Yu., Kiselev V.V. // Òàâðè÷åñêèé ìåäèêî-áèîëîãè÷åñêèé âåñòíèê (English Edition). – 2007. – Ò. 10, ¹ 3. – Ñ. 257-259.
500. The syntax of immune–neuroendocrine communication / J.E.
Blalock // Immunol Today. – 1994. – Vol. 15. – P. 504– 511.
501. Thompson E. Proteins of cerebrospinal fluid / E. Thompson. – Elsevier academic press, 2005. – 332 c.
502. Tortella F.C. Characterization of opioid peptide like anticonvul–sant activity in rat cerebrospinal fluid / Tortella F.C., Long J.B. // Brain Res. – 1988. – Vol. 456, ¹ 1. – P. 139–146.
Ñïèñîê èñïîëüçîâàííûõ èñòî÷íèêîâ 503. Tortella F.C. Endogenous anticonvulsant substance in cerebrospinal fluid in rats after generalized seizures / Tortella F.C., Long J.B. // Brain Res. – 1988. – Vol. 456, ¹ 1. – P. 439–441.
504. Torzewski M. Integrated cytology of cerebrospinal fluid / M.
Torzewski, K.J. Lackner, J. Bohl. – Springer–Verlag Berlin Heidelberg, 2008. – 93 p.
505. Unger H. The vasopressin and oxytocin content in the cerebrospinal fluid of rabbits under changed conditions / Í. Unger, Schwarzberg H., Schulz H // Ependima and neurohormonal regulation:
Proc. Internat. Symposium. – Bratislava., 1974. – P. 251–260.
Êàôåäðà 506. Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study / M.P. Van den Berg, P. Merkus, S.G. Romeijn et al. // Pharmaceutical Research. – 2004. – Vol. 21, ¹ 5. – Ð. 799–802.
íîðìàëüíîé 507. Urwin S.C., Hunt P. Cerebrospinal fluid filtration in Guillain Barre syndrome / Urwin S.C., Hunt P. //Anaesthesia. –2000. – Vol. 55, ¹ 5. –Ð. 503-504.
508. Van Duke H.B. Studying of cerebrospinal fluid / Í.Â. Van àíàòîìèè Duke, Balley Ð., Bucy Ð.Ñ. // Pharmakol. and Experim Therap. – 1929.
– Vol. 36. – P. 595–610.
509. Vanhala R. Low levels of insulin–like growth factor–I in cerebrospinal fluid in children with autism / R. Vanhala, U. Turpeinen, ÊÃÌÓ R. Riikonen // Developmental Medicine and Child Neurology. – 2001. – Vol. 43, ¹ 9. – P.614 – 616.
510. Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus / P.
Koehne, F. Hochhaus, U. Felderhoff–Mueser et al. // Child's Nervous System. – 2002. – Vol. 18, ¹ 3–4. – Ð. 137–141.
511. Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: Evidence for antecedent hypoxia / J.L. Kimberly, H.F. Krous, J. Nadeau, B.
Blackbourne // Pediatrics. – 2003. – Vol. 111, ¹ 2. – Ð. 358.
512. Wenkel H. Systemic immune deviation in the brain that does not depend on the integrity of the blood–brain barrier / H. Wenkel, J.W.
Streilein, M.J. Young // The Journal of Immunology. – 2000. – Vol. 164.
– P. 5125–5131.
188 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ 513. Wieser H.G. Rasmussen’s encephalitis new treatment strategies / Wieser H.G. // The Third YONSEI Epilepsy Symposium. – Seoul, 1996.
514. Wildt L. Hypothalamus. Reproductionsmedizin / Wildt L. // Ed Hrsg. Von Bettendorf G, Breckwoldt M. –Stuttgart: Fischer,1989. – P. 6–22.
515. Woo A.H.–T. Brain–immune system interactions: analysis of immunoglobulin A in cerebrospinal fluid / A.H.–T. Woo //Dissertation Abstracts International. – 1992. – Vol. 52, ¹ 9. – P. 4662.
516. Wybran J. Interrelations between the immune system and the Êàôåäðà central nervous system: physiological, and pathological consequences / Wybran J. // Acta Clin. Belg. – 1984. – Vol. 39, ¹ 3. – P. 131–135.
517. Wybran J. Neuroimmunoendocrinology / Wybran J. // Immunology today. – 1989. – Vol. 10, ¹ 9. – P. 319–325.
íîðìàëüíîé 518. Zhao W.G. Ñerebrospinal fluid Ig G, Ig A, Ig m, Ig D and Ig E levels in healthy individuals with related parameters analysis / Zhao W.G.,Yu Y.C., Li Y.D. // J. Neuroimmunol. – 1987. – Vol.16, ¹ 1. – P.
194.
àíàòîìèè 519. Zubrzycka M. Substance P content in the cerebrospinal fluid and fluid perfusing cerebral ventricles during elicitation and inhibition of trigemino–hypoglossal reflex in rats / Zubrzycka M., Janecka À. // Brain Research. – 2002. – Vo l. 941, ¹ 1–2. – Ð. 29–33.
ÊÃÌÓ Äëÿ çàìåòîê Êàôåäðà íîðìàëüíîé àíàòîìèè ÊÃÌÓ ÑÎÄÅÐÆÀÍÈÅ ÏÅÐÅ×ÅÍÜ ÓÑËÎÂÍÛÕ ÎÁÎÇÍÀ×ÅÍÈÉ................................... ÂÂÅÄÅÍÈÅ............................................................................................. Êàôåäðà ×àñòü 1. ÀÍÀÒÎÌÈß È ÔÈÇÈÎËÎÃÈß ËÈÊÂÎÐÍÎÉ ÑÈÑÒÅÌÛ............................................................................................ 1.1 Ýòàïû ðàçâèòèÿ ó÷åíèÿ î ñïèííîìîçãîâîé æèäêîñòè, òåðìèíîëîãèÿ.......................................................................................... íîðìàëüíîé 1.2 Àíàòîìèÿ, ôèëîãåíåç, îíòîãåíåç ëèêâîðíîé ñèñòåìû............ 1.3 Ñîñòàâ, ôèçèîëîãè÷åñêàÿ ðîëü ñïèííîìîçãîâîé æèäêîñòè... 1.4 Òåõíîëîãèÿ ïîëó÷åíèÿ è îáðàáîòêè ëèêâîðà êàê èñõîäíîãî ñûðüÿ äëÿ ïðîèçâîñòâà áèîãåííûõ ïðåïàðàòîâ................................... àíàòîìèè 1.5 Ñòðîåíèå è ôóíêöèîíàëüíîå çíà÷åíèå ãåìàòîýíöåôàëè÷åñêîãî áàðüåðà, åãî ðîëü â ðåãóëÿöèè ñîñòàâà ñïèííîìîçãîâîé æèäêîñòè, ïîíÿòèå î «ãóìîðàëüíîì ðåôëåêñå»..... 1.6 Ñïèííîìîçãîâàÿ æèäêîñòü êàê ãóìîðàëüíîå çâåíî ðåãóëÿöèè èììóííîãî ãîìåîñòàçà îðãàíèçìà........................................................ ÊÃÌÓ 1.7 Ãîðìîíàëüíûé ñòàòóñ ñïèííîìîçãîâîé æèäêîñòè êàê çâåíà íåéðîýíäîêðèííîé ñèñòåìû.................................................................. 1.8 Ñèñòåìà ñòâîëîâûõ êëåòîê, êàê ñîñòàâëÿþùàÿ ÷àñòü íåéðî èììóííî-ýíäîêðèííîé ðåãóëÿöèè ôóíêöèé â îðãàíèçìå................... ×àñòü 2. ÁÈÎËÎÃÈ×ÅÑÊÈÅ ÑÂÎÉÑÒÂÀ È ÒÅÐÀÏÅÂÒÈ×ÅÑÊÎÅ ÏÐÈÌÅÍÅÍÈÅ ÑÏÈÍÍÎÌÎÇÃÎÂÎÉ ÆÈÄÊÎÑÒÈ....................................................................................... 2.1 Èçìåíåíèå ñâîéñòâ, ñîñòàâà ñïèííîìîçãîâîé æèäêîñòè, ïðîíèöàåìîñòè ãåìàòîýíöåôàëè÷åñêîãî áàðüåðà ïðè ôèçèîëîãè÷åñêèõ ïðîöåññàõ, ýêñïåðèìåíòàëüíûõ âîçäåéñòâèÿõ è ðàçâèòèè ïàòîëîãè÷åñêèõ ñîñòîÿíèé.................................................. ÑÎÄÅÐÆÀÍÈÅ 2.2 Âëèÿíèå ñïèííîìîçãîâîé æèäêîñòè ïðè ïàðåíòåðàëüíîì åå ââåäåíèè íà îðãàíû íåéðîýíäîêðèííîé ðåãóëÿòîðíîé ñèñòåìû, ìåòàáîëè÷åñêèå ïðîöåññû, ðîñò, ïîëîâîå ñîçðåâàíèå…………… 2.3 Èñïîëüçîâàíèå ñïèííîìîçãîâîé æèäêîñòè äëÿ ëå÷åíèÿ ðàçëè÷íûõ çàáîëåâàíèé……………………………………………. 2.4 Ñàíàöèÿ ëèêâîðà: ìåòîäû ýêñòðàêîðïîðàëüíîé ëèêâîðîêîððåêöèè…………………………………………………. ÇÀÊËÞ×ÅÍÈÅ…………………………………………………… ÑÏÈÑÎÊ ÈÑÏÎËÜÇÎÂÀÍÍÛÕ ÈÑÒÎ×ÍÈÊÎÂ………….. Êàôåäðà ÑÎÄÅÐÆÀÍÈÅ…………………………………………………… íîðìàëüíîé àíàòîìèè ÊÃÌÓ 192 ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ Â.Ñ. Ïèêàëþê, Å.Þ. Áåññàëîâà, Â.Â. Òêà÷ (ìë.), Ì.À. Êðèâåíöîâ, Â.Â. Êèñåëåâ, Ë.Ð. Øàéìàðäàíîâà Êàôåäðà ËÈÊÂÎÐ ÊÀÊ ÃÓÌÎÐÀËÜÍÀß ÑÐÅÄÀ ÎÐÃÀÍÈÇÌÀ íîðìàëüíîé àíàòîìèè ÂÄ «ÀвÀË» Ñâ³äîöòâî ÄÊ ¹ 3562 â³ä 28.08.2009 ð.
ïðî âíåñåííÿ ñóá'ºêòà âèäàâíè÷î¿ ñïðàâè äî äåðæàâíîãî ÊÃÌÓ ðåºñòðó âèäàâö³â, âèãîò³âíèê³â òà ðîçïîâñþäæóâà÷³â âèäàâíè÷î¿ ñïðàâè.
97513, ÀÐ Êðèì, ѳìôåðîïîëüñüêèé ð-í, ñìò. Ãâàðä³éñüêå, âóë. Í.Ñàäîâà, á. òåë. (0652) 70-63-31, 050-648-89- e-mail:braznikov@mail.ru ϳäïèñàíî äî äðóêó ç îðèã³íàëó-ìàêåòó 09.09.2010 ð.
Ôîðìàò 60õ841/16. Ãàðí³òóðà «Times New Roman».
Óìîâí. äðóê. àðê. 12,0. Íàêëàä 300 ïðèì.
Çàìîâëåííÿ ¹. 402. Ö³íà äîãîâ³ðíà.
³ääðóêîâàíî ç ãîòîâèõ ä³àïîçèòèâ³â ó äðóêàðí³ ÔÎÏ Áðàæí³êîâî¿ Í.À.
ì. ѳìôåðîïîëü, âóë. Äåêàáðèñò³â, 21. îô. 105.
òåë. (0652) 70-63-31, 050-648-89-34.
å-mail: braznikov@mail.ru